Definitive Contract 75F40123C00210
Award Date
9/25/23
Potential Completion Date
9/29/26
Potential Value
$1.2M
Federal Agency
Food and Drug Administration
Awardee
Kaiser Foundation Hospitals
Ultimate Awardee
Kaiser Foundation Health Plan, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Silver Spring, MD 20993, USA
Solicitation Procedures
Basic Research
Number Of Offers Received
1
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
Kaiser Foundation Hospitals, doing business as Kaiser Permanente, was awarded a definitive cost-no-fee contract by the Department of Health and Human Services Food and Drug Administration (FDA) on September 26, 2018. The contract has a potential value of $5,646,115.20 and completion date of February 28, 2023. It concerns research on the effects of medical products on suicidal ideation and behavior through real world evidence, as initially solicited in a February 13, 2018 Broad Agency...
This federal contract award to Kaiser Foundation Hospitals, a division of the non-profit Kaiser Permanente healthcare system, is for biomedical research valued at $53,167,915.85. The award, made by the National Heart Lung and Blood Institute, a part of the National Institutes of Health, is a definitive contract with a cost-no-fee pricing type that runs through June 30, 2013. This contract does not have a set-aside designation. Kaiser Foundation Hospitals and its parent company, Kaiser Foundation...
Kaiser Foundation Hospitals Kaiser Foundation Research Institute Division, doing business as Kaiser Permanente, has been awarded a firm fixed price purchase order valued at $19,827.67 by the National Institutes of Health's National Institute on Drug Abuse. The contract is for Kaiser Permanente to finalize project objectives and scope for a patient cohort study, including eligibility criteria and intended outcomes. Performance will take place in Baltimore, Maryland over a one year period from...
This is a federal contract awarded by the National Heart Lung and Blood Institute, a civilian agency, to Kaiser Foundation Hospitals, Kaiser Foundation Research Institute Division, doing business as Kaiser Permanente. The contract has a ceiling value of $42,304,985.02 and is a definitive contract with a cost-no-fee pricing type. The contract is for biomedical (applied/exploratory) research and does not have a set-aside designation. Kaiser Permanente is a large, non-profit healthcare provider and...
This $1,986,836.74 firm fixed-price federal contract was awarded by the Centers for Disease Control and Prevention (CDC) to Kaiser Foundation Hospitals, doing business as Kaiser Permanente, a non-profit healthcare provider and research organization. The contract, awarded on July 1, 2021, supports FY 2021 Broad Agency Announcement (BAA) Topic 9 - KPSC, with a period of performance ending on September 30, 2022. This contract is not set aside for any small business categories. Kaiser Permanente...
This federal contract award is for $15,000.00 and was issued by the National Cancer Institute (NCI) to Kaiser Foundation Hospitals, doing business as Kaiser Permanente, for data services. The contract has an ultimate completion date of September 22, 2025 and is a firm fixed-price purchase order. Kaiser Foundation Hospitals is a prominent non-profit healthcare provider and research organization that has extensive expertise in medical research, clinical studies, and public health initiatives....
This federal contract award to Kaiser Foundation Hospitals, a subsidiary of Kaiser Foundation Health Plan, Inc., supports the Centers for Disease Control and Prevention's (CDC) efforts to improve identification and treatment of latent tuberculosis infection (LTBI) among high-risk non-U.S.-born populations in primary care settings. The $5,223,415 definitive contract, awarded on September 29, 2021 without a set-aside, will fund the development, implementation, and evaluation of LTBI intervention...
This is a purchase order award by the Centers for Disease Control and Prevention (CDC) to Kaiser Foundation Hospitals, a non-profit healthcare provider and research organization doing business as Kaiser Permanente. The $116,746 firm fixed-price contract, awarded on September 30, 2015, is for unspecified products or services with a completion date of December 31, 2016. The award is not set aside for any particular type of business. Kaiser Permanente is an established federal contractor that...
This federal contract was awarded by the Department of Health and Human Services Centers for Disease Control and Prevention to Kaiser Foundation Hospitals, doing business as Kaiser Permanente, a non-profit healthcare provider and research organization. The $100,381 firm fixed-price delivery order is for critical functions related to the Vaccine Safety Datalink Project, a long-running initiative between the CDC and various healthcare systems to conduct post-licensure vaccine safety monitoring and...
This is a definitive cost-type federal contract awarded to Kaiser Foundation Hospitals, a non-profit healthcare provider and research organization, to perform work in California. The contract does not have a set-aside designation. The total potential value of the contract is $409,910.00. The contract was awarded on January 15, 2000 with a completion date of January 31, 2006. Kaiser Foundation Hospitals, through its Kaiser Foundation Research Institute division, performs a wide range of...